When is the next results date for Sangani Hospital?

No Upcoming Board Meetings

Has Sangani Hospital declared dividend?

No Dividend History Available

What is the technical trend for Sangani Hospital?

As of May 3, 2025, Sangani Hospital's technical trend is mildly bullish, though mixed signals from various indicators suggest caution.

As of 3 May 2025, the technical trend for Sangani Hospital has changed from bullish to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and Bollinger Bands suggest a mildly bearish outlook. The weekly KST is bullish, but the overall weekly indicators, including OBV, are mildly bearish. The lack of signals from the RSI on both weekly and monthly time frames further supports a neutral stance in momentum. Overall, the current technical stance is mildly bullish, but with caution due to mixed signals across different indicators.

Who are the peers of the Sangani Hospital?

Sangani Hospital's peers include KHFM Hospitality, Maitreya Medica, Vaidya Sane, and others, with varying management risks and growth ratings. Sangani Hospital has a 1-year return of 45.05%, lower than Maitreya Medica's 119.67% but higher than Nidan Laborator's -41.34%.

Peers: The peers of Sangani Hospital are KHFM Hospitality, Maitreya Medica., Vaidya Sane, Lotus Eye Hospit, Aatmaj Health, Nidan Laborator., Fortis Malar, Shanmuga Hos., and KK Shah Hospital.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shanmuga Hos., while Average management risk is found at KHFM Hospitality, Maitreya Medica., and Lotus Eye Hospit, and the rest. Below Average management risk is present at Vaidya Sane, Sangani Hospital, Aatmaj Health, Nidan Laborator., Fortis Malar, KK Shah Hospital, and the rest. Growth is rated as Good for Vaidya Sane and Aatmaj Health, while Below Average growth is noted for KHFM Hospitality, Maitreya Medica., Lotus Eye Hospit, Sangani Hospital, Nidan Laborator., Fortis Malar, and the rest. Capital Structure is rated as Excellent at Shanmuga Hos., Good at Maitreya Medica., Vaidya Sane, Lotus Eye Hospit, Sangani Hospital, Aatmaj Health, and KK Shah Hospital, and Below Average at Nidan Laborator. and Fortis Malar.<BR><BR>Return Snapshot: Maitreya Medica. has the highest 1-year return at 119.67%, while Nidan Laborator. has the lowest at -41.34%. Sangani Hospital's 1-year return of 45.05% is significantly higher than Nidan Laborator. but lower than Maitreya Medica. Additionally, Aatmaj Health, Nidan Laborator., Fortis Malar, and KK Shah Hospital all have negative six-month returns.

What does Sangani Hospital do?

Sangani Hospitals Ltd is a multi-speciality hospital in Keshod, Gujarat, providing primary to tertiary care. It was incorporated in November 2021 and has a market cap of INR 91 Cr, with no recent revenue or profit data available.

Overview:<BR>Sangani Hospitals Ltd operates as a multi-speciality hospital providing primary, secondary, and tertiary care facilities, and is categorized as a micro-cap company in the hospital industry.<BR><BR>History:<BR>Sangani Hospitals Ltd was incorporated as a Public Limited Company in Keshod, Gujarat on November 11, 2021. The company received its Certificate of Incorporation on November 12, 2021, and its Certificate of Commencement of Business on December 14, 2021. Revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 91 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 35.00<BR>Industry P/E: 59<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.57<BR>Return on Equity: 7.73%<BR>Price to Book: 2.71<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the top shareholders of the Sangani Hospital?

The top shareholders of Sangani Hospital include Ajaykumar Natavarlal Sangani with 24.04%, individual investors with 24.3%, and Affluence Gems Private Limited as the largest public shareholder at 2.18%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Sangani Hospital include the promoters, with Ajaykumar Natavarlal Sangani holding the largest share at 24.04%. In addition, individual investors collectively hold 24.3% of the shares. The highest public shareholder is Affluence Gems Private Limited, which owns 2.18%. There is also one Foreign Institutional Investor (FII) that holds a small stake of 0.02%. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

How big is Sangani Hospital?

As of 24th July, Sangani Hospitals Ltd has a market capitalization of 89.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 33.49 Cr and Total Assets of 35.41 Cr; however, there is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

As of 24th July, <BR><BR>Market Cap: Sangani Hospitals Ltd has a market capitalization of 89.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 33.49 Cr and Total Assets totaling 35.41 Cr.

How has been the historical performance of Sangani Hospital?

Sangani Hospital has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 15.67 Cr in Mar'23 to 21.19 Cr in Mar'25. However, operating profit margins have decreased, and cash flow from operations has declined, indicating challenges in maintaining financial stability.

Answer:<BR>The historical performance of Sangani Hospital shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Sangani Hospital's net sales increased from 15.67 Cr in Mar'23 to 21.19 Cr in Mar'25, indicating a positive trend in revenue generation. The total operating income followed a similar trajectory, rising from 15.67 Cr in Mar'23 to 21.19 Cr in Mar'25. The total expenditure, excluding depreciation, also grew from 12.62 Cr in Mar'23 to 18.73 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) rose from 3.14 Cr in Mar'23 to 4.07 Cr in Mar'25, although the operating profit margin decreased from 19.46% in Mar'23 to 11.61% in Mar'25. Profit before tax showed an upward trend, increasing from 2.02 Cr in Mar'23 to 3.46 Cr in Mar'25, while profit after tax also rose from 1.48 Cr to 2.59 Cr during the same period. The consolidated net profit slightly decreased from 2.70 Cr in Mar'24 to 2.59 Cr in Mar'25. On the balance sheet, total assets increased significantly from 19.60 Cr in Mar'23 to 39.18 Cr in Mar'25, with total liabilities also rising from 19.60 Cr to 39.18 Cr. Cash flow from operating activities showed a decline from 3.00 Cr in Mar'24 to 2.00 Cr in Mar'25, contributing to a net cash outflow of 1.00 Cr in Mar'25. Overall, while Sangani Hospital has demonstrated growth in sales and profits, it faces challenges in maintaining operating margins and cash flow stability.

Is Sangani Hospital overvalued or undervalued?

As of November 24, 2025, Sangani Hospital is considered undervalued and attractive compared to its peers, with a PE ratio of 33.75, despite a year-to-date return of -12.96%.

As of 24 November 2025, Sangani Hospital's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, especially in comparison to its peers. Key ratios include a PE ratio of 33.75, an EV to EBITDA of 32.87, and a ROE of 6.98%. <BR><BR>When compared to its peers, Sangani Hospital stands out as more attractive than Max Healthcare, which has a PE ratio of 79.41 and is deemed very expensive, and Narayana Hrudaya, which has a PE of 47.49 and is classified as expensive. Despite recent underperformance, with a year-to-date return of -12.96% compared to the Sensex's 9.79%, the valuation metrics suggest that Sangani Hospital presents a compelling investment opportunity in the current market.

Which are the latest news on Sangani Hospital?

Why is Sangani Hospital falling/rising?

As of 04-Dec, Sangani Hospitals Ltd's stock price is at 62.00, unchanged from the previous session, with a year-to-date decline of 14.95% and a one-year decline of 20.51%. The stock is underperforming compared to the benchmark Sensex and shows mixed performance against its moving averages, indicating challenges in price movement and reduced investor participation.

As of 04-Dec, Sangani Hospitals Ltd's stock price is currently at 62.00, with no change from the previous trading session. The stock has experienced a decline over various periods, including a year-to-date decrease of 14.95% and a one-year decline of 20.51%. In contrast, the benchmark Sensex has shown positive performance, increasing by 10.10% year-to-date and 6.40% over the past year. <BR><BR>Today's performance is described as inline with the sector, but the stock is currently higher than its 5-day moving averages while being lower than its 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a mixed performance relative to its longer-term trends. Additionally, there has been a significant drop in investor participation, with delivery volume on December 1 falling by 59.46% compared to the 5-day average. <BR><BR>Overall, the combination of a declining stock performance relative to the benchmark, lower investor participation, and mixed moving averages suggests that Sangani Hospitals Ltd is facing challenges that may contribute to its stagnant price movement at 62.00.